Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company headed this year?

| More on:
A person holds a small glass jar of marijuana.

Source: Getty Images

Canopy Growth (TSX:WEED) has been one of the hardest hit cannabis stocks out there over the last few years. In fact, it might just be one of the hardest hit stocks, period! The company went from share prices around $70 per day, to lows of $2.79 in the last year. Even now, from those all-time highs, shares are down about 95% as of writing. That’s almost all of its value, gone.

But things could be different in 2023. It’s not guaranteed (nothing is), but it looks like a few developments are coming down the pipeline that could be beneficial for Canopy Growth stock. So let’s see what’s been going on, and what investors should look out for in 2023.

Fall 2022 was huge

Before we talk about the future, we need to talk about the past. At least the very recent past. And the Autumn was huge for Canopy Growth stock, and cannabis stocks in general if we’re honest. Finally, the White House came out stating that it would provide a pardon for individuals convicted of simple marijuana possession.

This was seen as a major step in the right direction for cannabis stocks like Canopy Growth stock. Is the White House basically saying, it’s fine to carry some weed on you? Huge. But it got even better. Over the coming months, several states also legalized the recreational use of marijuana, adding to the dozens already legalizing the product.

This led Canopy Growth stock to start its engines and announce it would fully acquire Acreage Holdings. The company already planned to do this, but wanted to wait for legalization or at least decriminalization on a federal level. So this was sooner than expected. Even so, the hope is that the company can now start the expansion process.

What now?

The main focus for Canopy Growth stock these days is one thing and one thing only: profit. It’s one of the few cannabis companies on a large scale that has yet to post a profit. However, it does seem to be on the right track, if we’re to believe its earnings reports.

Revenue grew 7% quarter over quarter, with a 299% increase in net revenue for its BioSteel operations. However, it also made a major announcement during the last quarter – that Canopy Growth stock would divest all of its Canadian retail operations. It would therefore focus on savings from selling, general and administration, and focus mainly on its cannabis operations instead.

Now onto 2023

There have been some major announcements in the last few months, and it could be gearing up for something great in 2023. The problem is, we’re still about to enter a recession. And that doesn’t bode well for consumption during that time.

Even still, it might be that this is the start, and by the end of 2023, we could see where Canopy Growth stock is headed in all this. It looks like it’s trying to create cost savings to reach profit, but also to continue its focus on cannabis production. Meanwhile, BioSteel will continue to bring in strong revenue, as will its new Acreage Holdings branches.

By the end of 2023, Canopy Growth stock may be entirely focused on its United States operations. Canada may simply be a support for the greater growth of the company. And honestly, if it means shares reach 52-week highs again, who cares?

Bottom line

It seems as though Canopy Growth stock is in a transition phase. What will come of it is anyone’s guess, but it looks like profit and its U.S. operations are the main focus. And with the U.S. set to be the largest cannabis consumer in the world, 2023 could prove to be the year that Canopy Growth stock comes back on top.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Here’s Why it’s Not Too Late to Buy Cronos Group Stock

The optimism about U.S. federal marijuana legalization and its anticipation are potent bullish triggers for the Canadian cannabis industry.

Read more »